Porphyromonas gingivalis promotes lipid droplet-mediated microglial dysfunction

Muhammad Shahid Riaz Rajoka1, Kristina Nicole Valladares1, Chloe La Prairie1

  • 1Department of Pediatric Dentistry, School of Dentistry, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Insights

Periodontitis-causing bacteria, Porphyromonas gingivalis, trigger lipid droplet buildup in microglia. This impairs their function and may accelerate Alzheimer's disease progression.

Area of Science:

  • Neuroimmunology
  • Microbial Pathogenesis
  • Neurodegenerative Diseases

Background:

  • Periodontitis and Alzheimer's disease (AD) share a strong association, but underlying mechanisms are unclear.
  • Microglia, the brain's immune cells, show lipid droplet accumulation and dysfunction in neurodegenerative disorders like AD.
  • Porphyromonas gingivalis (Pg) is a key pathogen in periodontitis.

Purpose of the Study:

  • To investigate if Porphyromonas gingivalis (Pg) induces lipid droplet (LD) accumulation in microglia.
  • To determine the impact of Pg-induced LD accumulation on microglial function.
  • To explore the role of lipid metabolism in microglial dysfunction during periodontitis.

Main Methods:

  • Infection of BV2 microglial cells and microglia from Pg-infected App KI mice with Porphyromonas gingivalis.
  • Assessment of lipid droplet accumulation, reactive oxygen species (ROS) production, and phagocytic ability.
  • Pharmacological inhibition of lipid droplet synthesis using a triglyceride synthesis inhibitor.

Main Results:

  • Pg infection robustly increased LD accumulation in microglia.
  • Pg-induced LD buildup correlated with increased ROS production, impaired phagocytosis, and altered microglial activation.
  • Inhibiting LD synthesis reversed these functional deficits, highlighting lipid metabolism's role.

Conclusions:

  • Porphyromonas gingivalis promotes lipid droplet accumulation in microglia, contributing to their dysfunction.
  • This microglial metabolic alteration exacerbates oxidative stress and impairs phagocytosis, potentially accelerating Alzheimer's disease progression.
  • Targeting lipid metabolism may offer a therapeutic strategy for periodontitis-associated neuroinflammation.